Access cutting-edge sickle cell disease treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access sickle cell disease specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sickle cell disease treatment provided free
The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics, pH and food effect, and preliminary efficacy of BMS-986470 in healthy volunteers and participants with sickle cell disease.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this sickle cell disease clinical trial in Chicago, IL
If you're searching for sickle cell disease treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sickle cell disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.